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Background: The intermittent access 2-bottle choice (IA2BC) and drinking in the dark
(DID) models were developed for studying rodent binge-like consumption. Traditionally,
IA2BC was used with rats and DID with mice. Recently, IA2BC was adapted to study
mouse ethanol consumption. However, it is unknown whether DID is suitable for rats or if
one rat model is more advantageous than another for studying binge-like consumption.
Methods: Male Wistar rats consumed 20% ethanol or 5% sucrose using IA2BC or DID
for 12 weeks. IA2BC drinking sessions occurred on alternate days (Mondays–Fridays)
and lasted 24 h, whereas DID sessions ran 4 h/day, 5 days/week (Monday–Friday).
Average consumption/session, week and hour was measured. To explore DID model
suitability for screening novel compounds for controlling ethanol and sucrose intake,
varenicline (2 mg/kg) or vehicle was administered to DID rats.
Results: IA2BC rats consume more ethanol/session and similar amounts of
ethanol/week than DID rats. While, IA2BC rats consume more sucrose/session and
week than DID rats. Although IA2BC rats had more ethanol and sucrose access time,
DID rats had greater ethanol and sucrose intake/hour. Varenicline significantly reduced
ethanol and sucrose consumption in DID rats, consistent with previously published
IA2BC studies.
Conclusions: Despite the shorter access time, the rat DID model induced higher initial
intake and greater consumption/hour for both ethanol and sucrose. The shorter duration
of DID sessions did not prevent detection of varenicline-induced reductions in ethanol or
sucrose consumption, suggesting the DID model may be suitable for studying binge-like
ethanol and sucrose consumption.
Keywords: intermittent access 2-bottle choice, drinking in the dark, ethanol, sucrose, varenicline, rat,
consumption model
Abbreviations: ADE, alcohol deprivation effect; AUD, alcohol use disorder; BEC, blood ethanol concentration; CDC, Center
for Disease Control and Prevention; DID, drinking in the dark; FDA, Federal Drug Administration; IA2BC, intermittent
access 2-bottle choice; NIAAA, National Institute on Alcohol Abuse and Alcoholism; NIH, National Institutes of Health;
s.c., subcutaneous; WHO, World Health Organization.
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INTRODUCTION
Harmful consumption of substances, like alcohol and sugar,
remain a world-wide health problem. In 2012, 3.3 million deaths
were attributed to alcohol consumption and in 2010, 3.4 million
deaths to being overweight or obese, with excessive sugar
consumption identified as a leading cause of body weight gain
(WHO, 2014). With few effective interventions and treatments
available, there remains a critical need for the development
of new medications and management strategies for reducing
alcohol and sugar intake. Rodent consumption models are
valuable tools for examining themechanisms underlying harmful
consumption behaviors and developing new therapies. Both
rodent species offer advantages and disadvantages for modeling
consumption and sometimes the use of a rat model is preferable
to a mouse model. For example, rats are generally larger
than mice and consequentially have larger brains, allowing the
study of smaller brain regions and more accurate placement
of cannula, viruses and other probes. Rats also have a slower
metabolic rate which expands the timeframe available to
measure the effects of potential interventions (like exercise and
pharmacotherapeutics) on consumption and reward seeking
behaviors. Studies examining the alcohol deprivation effect
(ADE) in rats generally produce more consistent results as
the ADE last for up to 4 days following the reintroduction of
ethanol compared to 1 day in mice (Vengeliene et al., 2014).
Additionally, mouse ethanol consumption behaviors differ from
rat behaviors. Specifically, mice consuming ethanol using the
drinking in the dark model (DID) model, compared to rats
using the intermittent access 2-bottle choice (IA2BC) model,
display greater insensitive to quinine adulteration of ethanol
(a test designed to measure ethanol dependence) making it
difficult to dissect the natural compulsive behaviors of the mouse
from compulsive behaviors associated with ethanol exposure
(Hopf and Lesscher, 2014). However, transgenic mice are
more readily available than transgenic rats for isolating genes
and signaling pathways involved in modulating consumption
behaviors. Hence, it is essential for the researcher to have a
diverse and adaptable range of tools and models available for
studying all aspects of consumption and related behaviors in both
species.
The recent development of two new preclinical rodent
models of consumption (DID and IA2BC) has improved our
ability to screen and identify novel pharmacotherapeutic targets
for the management of consumption behaviors. These models
were originally designed to mimic clinically relevant aspects
of human addiction defined in the Diagnostic and Statistical
Manual (American Psychiatric Association, 2013). Generally,
these models are considered to model binge-like consumption
as ethanol consumption was demonstrated to be greatest in
the period immediately following the start of the drinking
sessions (Rhodes et al., 2005). Typically, to more closely model
humans, the rodent commences ethanol consumption using
these models during adolescence. Many alcoholics report their
first ethanol experiences in their teens, a period where the
perception of negative properties of alcohol is reduced, leading
to a greater propensity for binge consumption and increased
risk for developing alcohol use disorders (AUDs) later in life
(Clapper and Lipsitt, 1992; Bonomo et al., 2004; Wells et al.,
2004). Additionally, preclinical research indicates that exposure
to ethanol commencing in adolescence keeps the brain in
an adolescent-like state in adulthood (Nielsen et al., 2012b),
providing insight into why commencing ethanol consumption in
adolescents results in greater ethanol consumption compared to
those commencing ethanol consumption as adults (Vetter et al.,
2007). Sucrose, on the other hand, was traditionally used in these
models as a natural reward control, to demonstrate the effects
of the novel compound were specific to ethanol consumption
and not consumption in general. However, with the recent
accumulation of evidence supporting the addictive properties of
sugar and its ability to modulate the same reward pathway that
drugs of abuse act upon (for reviews, see Avena et al., 2008;
Benton, 2010), the IA2BC andDIDmodels are increasingly being
used to study sucrose consumption (for examples, see Galic and
Persinger, 2002; Steensland et al., 2010; Mangabeira et al., 2015;
Shariff et al., 2016).
Two-bottle choice (2BC) models, like the IA2BC and DID
models are often chosen for studying consumption behaviors as
they are technically simple and accessible to most researchers,
and generally facilitate levels of consumption that are considered
clinically relevant to the targeted human condition (for reviews,
see McBride and Li, 1998; Carnicella et al., 2014; Griffin, 2014).
They also provide the rodent the opportunity to choose how
much ethanol or sucrose they wish to consume—a desirable
model quality since the loss of control over the ability to choose
not to consume the desired substance, despite being aware of
the negative consequences, is a defining criterion for addiction
(American Psychiatric Association, 2013). Many 2BC models
also involve intermittent periods of access to ethanol. This type of
consumption/withdrawal cycle can produce escalating binge-like
patterns of consumption, intoxication and withdrawal symptoms
during periods of abstinence, which are also indicators of
dependence (American Psychiatric Association, 2013; Carnicella
et al., 2014).
Currently, the IA2BC and DID models are the only two
voluntary consumption models available which can produce
moderate to high levels of ethanol consumption in rodents
without using sucrose-fading to induce ethanol consumption
and are generally considered models of binge-like consumption.
Wise (1973) first developed the IA2BC model. Simms et al.
(2008) extended this work, showing the IA2BC model could
be used to produce rats which consumed 20% ethanol at high
levels (∼5–6 g/kg/24 h), with approximately 30% of the rats
achieving BECs around 90–100 mg/dL—meeting one of the
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
criteria for binge drinking in humans (National Institute on
Alcohol Abuse and Alcoholism (US) (2004)). Additionally,
comparison of the IA2BCmodel with the traditional (non-binge-
like) 10% continuous access 2BC model demonstrated a 40%
increase in total ethanol consumption and improved sensitivity
for detecting changes in ethanol consumption following
administration of two different Federal Drug Administration
(FDA) approved AUDmedications, highlighting the importance
of providing intermittent over continuous access to ethanol
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(Simms et al., 2008). The IA2BC model involves providing rats
with access to one bottle of water and one of ethanol for 24 h
on alternative days (Monday, Wednesday and Friday). Around
the same time, work by Rhodes et al. (2005) demonstrated that
the DID model could produce consumption of 20% ethanol at
high levels (∼2–3 g/kg/2 h and ∼7 g/kg/4 h) and achieved blood
ethanol concentrations (BECs) above 100mg/dL inmice (Rhodes
et al., 2005). The DID model provides mice with access to one
bottle of water and one of ethanol for 2–4 h, 3 h into the dark
phase of the light cycle, Monday to Friday.
Since the publication of both these models, the IA2BC model
has predominantly been used to study ethanol consumption
in rats and the DID for studies in mice, with both models
demonstrating translation of discovered novel compounds
into human clinical trials (for examples see Lhuintre et al.,
1990; Mitchell et al., 2012). While the IA2BC is simple
to use and accessible to most researchers, it has fewer
consumption/withdrawal cycles per week (3 cycles/week)
compared to the DID model (5 cycles/week), thereby offering
fewer exposures to and withdrawals from ethanol per week in the
same time-frame as the DID model. This becomes particularly
important when conducting dose curve studies with novel
compounds. Typically, the first day of the week is used to
establish stable baseline drinking levels, the second day for the
administration of one dose of the compound being examined
and the third day to re-establish baseline consumption and
eliminate any potential rebound effects. This means that the
completion of dose curve studies using the IA2BC model can
take over a month to complete as there are only three drinking
sessions per week and only one dose can be tested per week. The
DID model, on the other hand has five drinking sessions per
week, producing more exposures in a shorter time period and
potentially allowing two different doses to be tested per week.
Using the IA2BC model for a dose curve study can result in
significant differences in both the age of the rat and number of
ethanol or sucrose exposures at which each dose is administered.
While a latin square design is used to compensate for these
differences, there is still the potential for increased noise and
false negatives. Additionally, the dramatic rise in global rates
of obesity and the subsequent burden of care faced by society
has led to an increasing need for the development of rodent
models for studying harmful sucrose consumption and its
effects on the brain. Given the similarities between the effects of
sucrose and other addictive substances on the reward pathway
(Lemon et al., 2004; Spangler et al., 2004; Lenoir et al., 2007),
ethanol consumption models are increasingly being adapted
to study sucrose consumption. We recently utilized the IA2BC
model in Wistar rats to show long-term binge-like sucrose
consumption leads to morphological changes in the nucleus
accumbens (Klenowski et al., 2016). We also demonstrated
that varenicline, a partial agonist at α4β2 subunit containing
nicotinic acetylcholine receptors, previously shown to reduce
nicotine and ethanol consumption (Coe et al., 2005; Steensland
et al., 2007), also reduces sucrose consumption (Shariff et al.,
2016).
While ethanol and/or sucrose consumption studies have been
conducted in mice using both the IA2BC and DID models
and rats using the IA2BC model, it is currently unknown
whether the DID model can be directly transferred to rats or
if there are any benefits of using one model over the other
for studying ethanol or sucrose binge-like consumption in rats.
Specifically, it is unknown whether one model produces greater
binge-like consumption than the other or if one model is
more suitable for studying sucrose verses ethanol consumption
behaviors. Here, we compare the DID and IA2BC models in
Wistar rats consuming ethanol or sucrose. We explore whether
the ethanol DID rat model meets the NIAAA binge drinking
criteria. Additionally, we examine whether the reduced access
time of the DID model impacts the efficacy of varenicline, a
compound previously shown to reduce both ethanol and sucrose
consumption using the rat IA2BC model (Steensland et al., 2007;
Shariff et al., 2016).
MATERIALS AND METHODS
Drugs
Five percent (w/v) sucrose (Sigma, ST. Louis, MO, USA)
and 20% (v/v) ethanol solutions (Chem-supply, SA, Australia)
were prepared in filtered water. Varenicline (6,7,8,9-tetrahydro-
6,10-methano-6H pyrazino[2,3-h][3]benzazepine tartrate) was
purchased from Tocris (Bristol, UK).
Animals and Housing
Five week old male Wistar rats (193.7 ± 15.8 g; Animal
Resource Centre, Perth, WA, Australia), were individually
housed in ventilated Plexiglas cages (Tecniplast, Italy). The
rats were acclimatized to the individual housing conditions,
handling and reverse-light cycle for 5 days before the start of
the experiments. All rats were housed in a climate-controlled
12-h reversed light cycle (lights off 9 am: lights on 9 pm)
room with unlimited access to standard rat chow and water.
The experimental procedures followed the ARRIVE guidelines
(https://www.nc3rs.org.uk/arrive-guidelines) and were approved
by the Queensland University of Technology Animal Ethics
Committee and the University of Queensland Animal Ethics
Committee, in accordance with the National Institutes of Health
(NIH) guidelines for the care and use of laboratory animals.
Intermittent-Access Two-Bottle Choice
Model
The IA2BC drinking procedure was performed as previously
described (Steensland et al., 2007; Shariff et al., 2016). All fluids
were presented in 300-ml graduated plastic bottles with stainless-
steel drinking spouts inserted through two grommets in the front
of the cage immediately following the commencement of the dark
phase of the light cycle (9 am). As previously reported, two bottles
were presented simultaneously: one bottle containing water; the
second bottle containing 5% (w/v) sucrose (Nielsen et al., 2008;
Simms et al., 2011, 2012; Srinivasan et al., 2012; Klenowski et al.,
2016; Patkar et al., 2016; Shariff et al., 2016) or 20% (v/v) ethanol
(Steensland et al., 2007; Nielsen et al., 2008; Simms et al., 2008,
2010, 2012, 2014; Bito-Onon et al., 2011; Mill et al., 2013; Augier
et al., 2014; Carnicella et al., 2014; Feduccia et al., 2014). The
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FIGURE 1 | Experimental timeline for the intermittent access 2-bottle choice (IA2BC) and drinking in the dark (DID) models. Five week old male Wistar
rats are given 1 week to habituate to the experimental housing conditions before commencing consumption of 20% ethanol or 5% sucrose using the IA2BC (A) or
DID (B) models. Rats consuming ethanol using the DID model also had blood collected for blood ethanol concentration (BEC) measurement after 10 weeks of
drinking sessions. After 12 weeks of ethanol or sucrose consumption, DID rats received 2 once weekly injections of vehicle or 2 mg/kg varenicline in pseudorandom
order, such that each rat served as their own control.
placement of the sucrose/ethanol bottle was alternated with each
exposure to control for side preferences. Bottles were weighed
30 min, 2 h and 24 h after the fluids were presented, with
measurements taken to the nearest 0.1 g. The weight of each rat
was also measured to calculate the grams of sucrose or ethanol
intake per kilogram of body weight. On the Monday after the
end of the housing acclimatization period, rats (193.7 ± 15.8 g,
n = 8 per group) were given access to one bottle of sucrose or
ethanol and one bottle of water. After 24 h, the sucrose/ethanol
bottle was replaced with a second water bottle that was available
for the next 24 h. This pattern was repeated on Wednesdays and
Fridays; all other days the rats had unlimited access to 2 bottles
of water for 60 drinking sessions (see Figure 1A). For the sucrose
experiments, due to technician error the measurements were not
recorded at the 30 min and 2 h time points for the first 2 weeks of
exposure (sessions 1–6, inclusive) and all measurements ceased
after session 35 (n = 12). While measurements were not recorded
the rats continued to have access to sucrose during this time. For
the ethanol experiments, measurements were collected at all time
points from session 1 through 60 (n = 8).
Drinking in the Dark Two-Bottle Choice
Model
The DID 2BC model was originally adapted from Rhodes et al.
(2005) and modified to a 4 h daily access procedure for studying
long-term ethanol consumption in mice by Santos et al. (2013).
We used the methods described by Santos et al. (2013) in
rats. The housing conditions, bottles and fluid concentrations
were kept identical to the IA2BC procedure described above.
However, the bottles were presented daily (Monday to Friday)
for 4 h, 3 h following the commencement of the dark phase
of the light cycle (12 pm) and bottle measurements were taken
at 30 min, 2 h and 4 h after the fluids were presented. Drug
administration began after the rats (n = 8 per group) had
been consuming ethanol or sucrose for 10–12 weeks as the
effects of ethanol and sucrose on the brain and the efficacy
of varenicline are more robust following long term exposure
(Klenowski et al., 2016; Patkar et al., 2016; Shariff et al.,
2016). As previously described (Steensland et al., 2007; Patkar
et al., 2016; Shariff et al., 2016), varenicline (2 mg/kg) or
vehicle (0.9% saline) were administered by subcutaneous (s.c.)
injection, 30 min before the drinking session, once per week
over 2 weeks at a volume of 1 ml/kg using a Latin square
design, such that each rat received both doses and served as
their own control. For both the ethanol (n = 8) and sucrose
(n = 8) experiments, all measurements were collected at all
time points from session 1 through 65 but only sessions
1–50 are used to assess baseline consumption due to blood
collection in week 10 and drug testing in weeks 12 and 13 (see
Figure 1B).
Blood Ethanol Measurements
The rats were anesthetized with isoflurane and tail blood
collected 30 min after bottle presentation in the 10th week
of ethanol consumption. Approximately 100 µl of whole
blood was collected into tubes containing 10 µL of 2.5 M
EDTA. The blood was centrifuged at 4◦C for 20 min at
1500× g and the serum aliquoted and stored at −80◦C
until assayed. BECs were determined using the nicotinamide
adenine dinucleotide (NAD)—alcohol dehydrogenase (ADH)
spectrophotometric assay as previously described (Zapata
et al., 2006; Santos et al., 2013). All reagents used in this
assay were purchased from Sigma-Aldrich (St. Louis, MO,
USA). All samples and standards were run in triplicate
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and BECs were calculated using a standard calibration
curve.
Statistics
Statistical analysis was performed using GraphPad Prism
software (version 6, USA) and all results are expressed as
mean ± standard error of the mean (SEM). Unpaired T-test
with Holm-Sidak method (alpha value adjusted to 0.017 using
Sidak correction) was used to compare consumption at each time
point and to compare vehicle and varenicline treatments at each
time point. Unpaired, two-tailed Student’s T-test was used to
compare hourly and weekly consumption. Linear Regression and
Pearson’s r coefficient were performed for the BEC and ethanol
consumption of each DID rat. Multiple t-tests with Holm-Sidak
correction (alpha = 0.010) were used to compare consumption
at each time point, per week and per hour for each model and
reinforcer.
RESULTS
Comparing Ethanol Consumption per
Drinking Session Using the IA2BC and DID
Models
To determine whether the DID model could be used to
induce high ethanol consumption in rats, we compared the
average ethanol consumption per drinking session for the first
50 sessions in rats using the DID model with rats using the
established IA2BC model (for review of IA2BC model see
Carnicella et al., 2014). In this study, the average amount
of ethanol consumed in the first 30 min was greater for
DID rats (0.73 ± 0.077 g/kg/30 min) compared to IA2BC
rats (0.81 ± 0.074 g/kg/30 min; Figure 2A, unpaired T-test
with Holm-Sidak correction, p = 0.0130, n = 8). The average
amount of ethanol consumed after 2 h ethanol access was
similar for IA2BC and DID rats (1.28 ± 0.098 g/kg/2 h and
1.23 ± 0.093 g/kg/2 h, respectively; Figure 2B, T-test with
Holm-Sidak correction, p = 0.5087, n = 8). However, the average
amount of ethanol consume during the entire drinking session
was greater for IA2BC rats (3.34± 0.362 g/kg/24 h) compared to
DID rats (1.83± 0.140 g/kg/4 h; Figure 2C, unpaired T-test with
Holm-Sidak correction, p< 0.0001, n = 8).
DID and IA2BC Rats Consume Similar
Amounts of Ethanol per Week
Although the rats using the IA2BC model consumed more
ethanol per session compared to the DID model, each model
possessed differences in the amount of time available per session
to access ethanol and the number of drinking sessions per
week. First, different lengths of time were needed to reach
the same number of drinking sessions for each model. For
example, the IA2BC rats needed to drink for 10 weeks to
complete 30 sessions whereas the DID rats only needed to
drink for 6 weeks to complete the same number of drinking
sessions. Second, the amount of time the rats were able
to access the ethanol per week was different between the
models: the IA2BC rats had 3 × 24 h sessions (72 h) per
week compared to 5 × 4 h sessions (20 h) per week for
the DID rats. To determine how the weekly differences in
ethanol access (session time and number) affected the total
amount of ethanol the rats received, we compared the average
amount of ethanol consumption per week (Figure 3A). We
also compared the average amount of ethanol consumed per
hour (Figure 3B) for each model. Using unpaired two-tailed
Student’s T-test we found no difference in the amount of ethanol
consumed per week (IA2BC: 10.56 ± 1.163 g/kg/week and
DID: 8.94 ± 0.687 g/kg/week, p = 0.2626, n = 8). However,
the amount of ethanol consumed per hour was greater for
the DID rats (0.46 ± 0.013 g/kg/h) compared to IA2BC rats
(0.14 ± 0.007 g/kg/h; unpaired two-tailed Student’s T-test,
p< 0.0001, n = 8).
Assessing the DID Model Against NIAAA
Binge Drinking Criteria
In 2004, the NIAAA set out criteria for defining binge drinking
in humans. A binge drinking session was defined as a pattern
of drinking alcohol that causes a blood alcohol concentration of
at least 80 mg/dL, which equates to approximately five or more
drinks consumed by an adult male in 2 h (National Institute
on Alcohol Abuse and Alcoholism (US) (2004)). We estimated
FIGURE 2 | Comparison of ethanol consumption per session using the IA2BC and DID models. (A) Rats using the DID model (gray) consumed more 20%
ethanol than IA2BC rats (white) following 30 min of ethanol access. (B) However, following 2 h of ethanol access, both the DID and IA2BC rats consumed similar
amounts of ethanol. (C) The total amount of ethanol consumed per session was greater for rats using the IA2BC model compared to the DID model. n = 8. Unpaired
T-tests with Holm-Sidak correction (alpha = 0.017). #p < 0.017, ####p < 0.0001 compared to IA2BC rats.
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FIGURE 3 | Comparison of weekly and hourly ethanol consumption using the IA2BC and DID models. (A) Rats consuming 20% ethanol using the DID
(gray) and IA2BC (white) model consumed similar amounts of ethanol per week. (B) However, the average amount of ethanol consumed per hour was greater for rats
using the DID model compared to the IA2BC model n = 8 per group. Two tailed unpaired Student’s T-test. ∗∗∗∗p < 0.0001 compared to IA2BC rats.
that an average adult male would need to consume around
0.87 g/kg in 2 h to meet the criteria of binge drinking based
on one standard drink containing 14 g of pure alcohol (CDC,
2016) and 80.7 kg for the average body weight of an adult in
North America (Walpole et al., 2012). However, we could not
find similar criteria for binge-like consumption for rodents in
the literature and it appears most rodent models of consumption
have been designed based on human criteria. As such, we were
limited to comparing the rodent consumption from each model
with the human binge criteria. Both the IA2BC and DID rats
consumed more than 0.87 g/kg during the first 2 h of their
ethanol consumption sessions (IA2BC: 1.28 ± 0.098 g/kg/2 h
and DID: 1.23 ± 0.093 g/kg/2 h). Next, we collected blood
from the DID rats to determine whether they reached BECs of
80 mg/dL or greater (BECs for IA2BC rats have been reported
previously, see Simms et al., 2008). We measured BECs 30 min
after the commencement of a standard drinking session during
the 10th week of ethanol consumption (as previously published
Steensland et al., 2007; Simms et al., 2008). Thirty minute BECs
were chosen over 2 h BEC measurements as rodent metabolic
rates are different to humans and previous studies indicate peak
BECs using the IA2BC model are achieved by this time point
in rodents (Simms et al., 2008; Cippitelli et al., 2012; George
et al., 2012). We compared 30 min BECs with the amount of
ethanol consumed during the 30 min prior to blood collection
(Figure 4). The average BEC was 24.45± 4.826 mg/dL and BECs
ranged from 14.24 to 54.00 mg/dL. Ethanol consumption in the
30 min prior to blood collection was 1.01 ± 0.153 g/kg/30 min,
ranging from 0.50 to 1.64 g/kg/30 min. There was a significant
correlation of BECs with ethanol consumption (R2 = 0.598,
p < 0.05). However, none of the DID rats BECs met the NIAAA
binge drinking criteria of 80 mg/dL after 30 min of ethanol
access.
Varenicline Reduces Ethanol Consumption
in DID Rats
Despite the differences in ethanol consumption per session,
the DID and IA2BC models resulted in the rats receiving
FIGURE 4 | Blood ethanol consumption correlates with ethanol
consumption with the DID model. Linear regression and Pearson’s
correlation coefficient were used to show that BEC increased with ethanol
consumption in rats using the DID model (r2 = 0.591, p = 0.026). n = 8 per
group.
similar amounts of ethanol each week and a higher initial and
hourly consumption rate in DID rats. Therefore, to examine
whether the differences in consumption produced by each model
and the differences in ethanol access times affected model
suitability for pre-clinical screening of novel compounds as
potential treatments for controlling ethanol consumption, we
next assessed whether the DID model could detect reductions
in ethanol consumption following treatment with varenicline.
Using the IA2BC model in rats, we have previously shown that
varenicline (2 mg/kg) reduces ethanol consumption following
30 min and 6 h of ethanol access (Steensland et al., 2007).
In this study using DID rats, varenicline also significantly
reduced ethanol consumption compared to vehicle at 30 min
(Figure 5A) and 2 h (Figure 5B) but not 4 h (Figure 5C)
following bottle presentation (Unpaired T-test with Holm-Sidak
correction, 30 min: p = 0.0003, 2 h: p < 0.0101, 4 h: p < 0.0232,
n = 8).
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FIGURE 5 | Varenicline reduces ethanol consumption in DID rats. Administration of 2 mg/kg varenicline (gray) produced a significant reduction in ethanol
consumption 30 min (A), 2 h (B) but not 4 h (C) after the commencement of a standard DID drinking session compared to vehicle (white). n = 8 per group. Unpaired
T-tests with Holm-Sidak correction (alpha = 0.017). #p < 0.017, ###p < 0.001 compared to vehicle.
Daily Sucrose Consumption Using the
IA2BC and DID Models
To determine whether the DID model could also be used to
study sucrose binge-like consumption in rats, we compared daily
sucrose consumption using the IA2BC and the DID model. As
demonstrated by Srisontiyakul et al. (2016), a significantly lower
concentration of sucrose is required to produce similar reward
seeking behaviors to ethanol, therefore 5% rather than 20%
sucrose was presented to the rats during drinking sessions. We
have recently shown long-term (10 weeks) consumption of 5%
sucrose using the IA2BC model leads to morphological changes
in the brain (Klenowski et al., 2016), indicating suitability of
this procedure for modeling the effects of long-term binge-like
sucrose consumption on the brain. Analysis using the unpaired
T-test with Holm-Sidak correction revealed that IA2BC rats
consumed similar amounts of sucrose than DID rats after
30 min but less sucrose compared to DID rats after 2 h
of sucrose access (30 min: Figure 6A, p = 0.0171 and 2 h:
Figure 6B, p < 0.0001). However, the IA2BC rats consumed
more sucrose per session than DID rats (Figure 6C, p< 0.0001).
The average amount of sucrose consumed using the IA2BC
model was 1.98 ± 0.085 g/kg/30 min, 3.58 ± 0.198 g/kg/2 h
and 19.85 ± 0.881 g/kg/24 h and for the DID model it
was 2.21 ± 0.138 g/kg/30 min, 4.52 ± 0.220 g/kg/2 h and
8.19± 0.410 g/kg/4 h.
The IA2BC Model Induces Greater Total
Sucrose Intake per Week
Next, to further examine the sucrose consumption produced
by each model, we compared the average amount of sucrose
consumed per week (Figure 7A) and the amount of sucrose
consumed per hour (Figure 7B). Using the unpaired, two-tailed
Student’s T-test we found rats using the IA2BCmodel consumed
more sucrose per week (p < 0.0001) but less sucrose per hour
(p < 0.0001) compared to DID rats. The IA2BC rats consumed
60.50 ± 2.731 g/kg of sucrose per week and 0.83 ± 0.022 g/kg
per hour whereas the DID rats consumed 37.30 ± 1.727 g/kg of
sucrose per week and 2.05± 0.045 g/kg per hour.
Varenicline also Reduces Sucrose
Consumption Using the DID Model
Given the differences daily, weekly and hourly consumption in
theDID and IA2BC rats, we wanted to knowwhether the reduced
access times of the DID model impacted the ability to detect
varenicline-induced reductions in sucrose consumption. We
have previously shown, using the IA2BC model, that varenicline
(2 mg/kg, s.c.) reduces sucrose consumption following 30 min
but not 2 h of sucrose access (Shariff et al., 2016). Similar to our
previous IA2BC study, varenicline significantly reduced sucrose
consumption compared to vehicle after 30 min (Figure 8A)
FIGURE 6 | Comparison of sucrose consumption per session using the IA2BC and DID models. Using the DID model (gray), rats consumed similar amounts
of 5% sucrose than rats using the IA2BC model (white) following 30 min (A) and more sucrose after 2 h (B) of sucrose access. (C) However, the total amount of
sucrose consumed per session was greater for rats using the IA2BC model compared to the DID model n = 8–12 per group. Unpaired T-tests with Holm-Sidak
correction (alpha = 0.017). ####p < 0.0001 compared to IA2BC rats.
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FIGURE 7 | Comparison of weekly and hourly sucrose consumption using the IA2BC and DID models. (A) Using the IA2BC model (white), rats consumed
more 5% sucrose per week compared to rats using the DID model (gray). (B) However, the average hourly sucrose intake was greater for DID rats compared to
IA2BC rats. n = 8–12 per group. Unpaired two-tailed Student’s T-test. ∗∗∗∗p < 0.0001.
FIGURE 8 | Varenicline reduces sucrose consumption in DID rats following 30 min of sucrose access. (A) Administration of 2 mg/kg varenicline (gray)
produced a significant reduction in sucrose consumption compared to saline (white) following 30 min of sucrose access using the DID model. Varenicline had no
effect on sucrose consumption at the 2 h (B) and 4 h (C) time points n = 8 per group. Unpaired T-tests with Holm-Sidak correction (alpha = 0.017).
##p < 0.01 compared to vehicle.
but not after 2 h (Figure 8B) or 4 h (Figure 8C) of sucrose
access in DID rats (Unpaired T-test with Holm-Sidak correction,
30 min: p = 0.0050, 2 h: p = 0.4095 and 4 h: p = 0.1889,
n = 6).
Comparison of Consumption between
Models and Reinforcers
To further explore the effect each model had on consumption
of ethanol and sucrose, we compared ethanol to sucrose
consumption produced by each model using multiple t-tests
with Holm-Sidak correction (alpha = 0.010). We compared
consumption after 30 min and 2 h, as well as per session, weekly
and hourly (Table 1). For both models, sucrose consumption was
significantly greater than ethanol consumption (p < 0.0001) for
all consumption parameters examined. Re-examination of each
of these parameters for each reinforcer (see Table 1) with this
statistical method produced similar results to those presented
above. Ethanol consumption was greater per session for the
IA2BCmodel (p< 0.001) but ethanol consumption per hour was
greater with the DID model (p< 0.0001). Both models produced
similar sucrose consumption after 30 min and 2 h. While sucrose
consumption was greater per session (p < 0.001) and per week
(p< 0.0001) using the IA2BCmodel, like ethanol consumptions,
hourly sucrose consumption was greater using the DID model
(p< 0.0001).
DISCUSSION
In this study, we demonstrate for the first time that rats will
consume moderate to high amounts of 20% ethanol and 5%
sucrose using the DID model, a model traditionally used with
mice. We compared their consumption to rats using the IA2BC
model and found they produced different consumption patterns
for ethanol and sucrose (see Table 1). While the IA2BC rats
consumed more ethanol per session than DID rats, the DID
rats displayed similar weekly consumption and higher initial and
hourly consumption of ethanol. Together, this suggested that
despite the IA2BC rats receiving 52 h more access to ethanol per
week, the DID model produced greater binge-like consumption,
particularly during the first 30 min of the drinking session.
Similarly, The IA2BC rats consumed more sucrose per session
and the DID rats displayed greater initial and hourly sucrose
consumption. However, unlike ethanol, the IA2BC rats displayed
greater weekly consumption of sucrose. Looking at ethanol and
sucrose consumption across time during a standard drinking
session for each model, DID rats consumed more ethanol than
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TABLE 1 | Comparison of ethanol and sucrose consumption for each model and reinforcer.
IA2BC DID
Consumption Ethanol Sucrose Ethanol Sucrose
g/kg/30 min 0.81 ± 0.074 1.98 ± 0.085∗∗∗∗ 0.73 ± 0.077 2.21 ± 0.138####
g/kg/2 h 1.28 ± 0.098 3.58 ± 0.198∗∗∗∗ 1.23 ± 0.093 4.52 ± 0.220####
g/kg/session 3.34 ± 0.362 19.85 ± 0.881∗∗∗∗ 1.83 ± 0.140$$$ 8.19 ± 0.410####,&&&
g/kg/week 10.56 ± 1.163 60.50 ± 2.731∗∗∗∗ 8.94 ± 0.687 37.30 ± 1.727####,&&&&
g/kg/hour 0.14 ± 0.007 0.83 ± 0.022∗∗∗∗ 0.46 ± 0.013$$$$ 2.05 ± 0.045####,&&&&
For each model and reinforcer multiple t-tests with Holm-Sidak correction (alpha = 0.010) were performed; n = 8–12 per group; ∗∗∗∗p < 0.0001 IA2BC ethanol compared
to IA2BC sucrose; ####p < 0.0001 DID ethanol compared to IA2BC Sucrose; $$$p < 0.001, $$$$p < 0.0001 IA2BC ethanol compared to DID ethanol; &&&p < 0.001,
&&&&p < 0.0001 IA2BC sucrose compared to DID sucrose.
IA2BC rats at 30 min but at 2 h their consumption was similar.
For sucrose the DID rats consumed similar amounts of sucrose
at 30 min and more sucrose at 2 h. This may imply that the rate
of sucrose consumption remains fairly consistent with time for
both models, and while the DID model appears to induce greater
binge-like sucrose consumption, the increased access time may
be beneficial for studying the effects of long-term excessive
sucrose consumption on the brain as it ensures exposure to
greater amounts of sucrose. However, the data presented in this
study indicate that the rate of ethanol consumption declines
as access time increases and the rate of decline is more rapid
for the DID compared to the IA2BC model. As such, the
longer period of access to ethanol provided by the IA2BC
model may not provide any additional benefits for studying
binge-like consumption or the effects of long-term excessive
ethanol consumption.
The differences in ethanol and sucrose consumption
behaviors (discussed above) are, most likely, a reflection of
the sedating effects of ethanol. Ethanol has both stimulatory
and sedating effects depending on the dose administered.
At low doses, ethanol increases locomotor activity, whereas
higher doses reduce locomotor activity and can lead to loss of
consciousness (June et al., 2003; Zapata et al., 2006; Kawakami
et al., 2007; Arias et al., 2012; Kippin, 2014; Botia et al., 2015;
Karlsson and Roman, 2016). As such, the more rapidly ethanol
is consumed and the greater the intake, the more sedated the
rat is likely to become, and the length of time the rat would
be capable of engaging in the further consumption of ethanol
would be reduced. Certainly, the elevated initial and hourly
ethanol consumption of the DID model combined with its
more rapid decline in ethanol consumption compared to the
IA2BC model indicate not only a greater propensity to induce
binge-like consumption but also a greater level of impairment.
However, our 30 min BEC data do not support greater levels
of impairment with the DID model compared to the IA2BC
model and it may be that 30 min BEC measures is not suitable
for use in rodents given their high metabolic rates (discussed
further below). Other measures of motor impairment (for
example, locomotor activity, rotarod, footprint analysis) are
required to determine whether one model produces greater
intoxication over the other. Sucrose exposure, on the other
hand, does not appear to alter locomotor activity (Avena
and Hoebel, 2003) and therefore, continued consumption of
sucrose would not be expected to alter the ability to continue
consumption. Measurements of locomotor activity during the
drinking sessions are needed to confirm this, particularly as
there is little data available regarding the effects of sucrose on
locomotor activity. Another possibility is that the differences in
consumption patterns observed result from differences in the
types of neuronal pathways that ethanol and sucrose are capable
of manipulating (for example, the reward pathway for ethanol
[for review, see Söderpalm and Ericson, 2013) vs. the appetitive
and reward pathways (Spangler et al., 2004) for sucrose], as
well as differences in the amount of neurotransmitters released
(Doyon et al., 2004; Funk and Dohrman, 2007) and the subtypes
of receptors involved (Hodge et al., 1994). Unfortunately,
many studies conducted which investigate these factors have
compared sucrose consumption with sucrose-sweetened
ethanol solutions (Hodge et al., 1994; Slawecki et al., 1997;
Doherty and Gonzales, 2015) making it difficult to isolate the
effects of ethanol alone. Future research is likely to address
this now that voluntary 2BC models are available that do
not require sucrose-fading to induce higher levels of ethanol
consumption.
As a large proportion of the total ethanol consumed occurred
during the initial period of the drinking session and the rate
of ethanol consumed per hour for the DID model was higher
than the IA2BC model (see Table 1), we examined the rat DID
model to see if it could be defined as a model of human binge
alcohol consumption. The first of the NIAAA defined criterion
required the consumption of five or more standard drinks within
2 h (National Institute on Alcohol Abuse and Alcoholism (US)
(2004)). We estimated that this was the equivalent of 0.87 g/kg in
2 h for the average adult male. The ethanol consumption for the
IA2BC and DIDmodels easily exceeded this criterion, suggesting
both procedures effectively model binge drinking. However, we
were unable to achieve the second NIAAA criterion for binge
drinking: BECs at or above 80 mg/dL (National Institute on
Alcohol Abuse and Alcoholism (US) (2004)) after 30 min of
access to ethanol. Previously, we reported that Wistar rats and
alcohol preferring (P) rats consuming 20% ethanol with the
IA2BC model achieved BECs 4–93 mg/dL and 11–63 mg/dL
(respectively) after 30 min of ethanol access (Simms et al., 2008).
While approximately 30% of the Long Evans rats in the study
achieved BECs above 90 mg/dL, only one of the Wistar and
none of the alcohol preferring (P) rats achieved a BEC above
80 mg/dL using the IA2BC model (Simms et al., 2008). The
range of the DID rats BECs (14.24–54.00 mg/dL) in this study
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was consistent with the previously reported BECs obtained using
the IA2BC model. Based on this it seemed possible, regardless
of the model used, 30 min may not be sufficient time for the
rats to drink enough alcohol to achieve a BEC of 80 mg/dL.
However, data from other IA2BC studies using Wistar rats
suggest that peak BECs occur by 30min and increasing the length
of ethanol access prior to BECmeasurement does not increase the
BEC obtained. Cippitelli et al. (2012) reported that Wistar rats
consuming ethanol for 1 h had BECs ranging from 7 mg/dL to
61 mg/dL after consuming around 5.2 g/kg of ethanol. Extending
the ethanol access time to 2 h produced BECs of approximately
58 mg/dL following consumption of about 3.6 g/kg of ethanol
(George et al., 2012). A more likely possibility is that the higher
metabolic rate and smaller body size of rats (compared to
humans) makes it difficult for the rats to consume a sufficient
amount of ethanol to reach the 80 mg/dL defined for humans in
the NIAAA binge drinking criteria. Some studies with mice have
utilized pyrazole, an alcohol dehydrogenase (ADH) inhibitor,
to prevent ethanol metabolism, and allow more consistent BEC
measurement (Terdal and Crabbe, 1994; Griffin et al., 2009).
Further studies are required to determine the time after ethanol
access commences that peak BECs occur and to explore whether
the use of pyrazole is required for rat BEC studies. Whether
a BEC of 80 mg/dL or more is an appropriate measurement
for classifying binge drinking in rodents also remains to be
explored.
Finally, we assessed whether the rat DID model could be
used to measure changes in ethanol and sucrose consumption
following treatment with varenicline, a compound previously
shown to reduce both ethanol and sucrose consumption using
the IA2BC model in Wistar rats (Steensland et al., 2007; Shariff
et al., 2016). Given the differences in the number of drinking
sessions per week and ethanol and sucrose access times between
the IA2BC and DIDmodels, we chose to use varenicline at a dose
of 2 mg/kg as we have previously shown this dose significantly
reduced ethanol (Steensland et al., 2007) and sucrose (Shariff
et al., 2016) consumption following two different lengths of
exposure (4 and 12 weeks), whereas the lower dose of 1 mg/kg
was only effective following 12 weeks of exposure to ethanol.
Similar to previously demonstrated with the IA2BC model,
varenicline reduced consumption at the 30 min and 2 h time
points for ethanol and only at the 30 min time point for sucrose.
However, we failed to demonstrate a significant effect at the
4 h time point for Varenicline on ethanol consumption, which
we had shown with the IA2BC model (Steensland et al., 2007).
Most likely this is due to differences in the statistical analysis
as the previous study did not correct for multiple t-tests. In the
present study, the p value was less than 0.05 at 4 h and without
the alpha value correction this could be considered significant.
While there is the possibility that use of the alpha adjustment
increases the amount of type II error, it is generally considered
the more suitable statistical test as it reduces the amount of type
I error when using multiple t-tests. Considering this, the level of
significance achieved was also similar to that obtained with the
IA2BC model for both ethanol and sucrose, indicating that the
DID model may have similar sensitivity to the IA2BC model for
screening novel compounds. Further testing with lower doses,
additional time points and other compounds known to reduce
ethanol and sucrose consumption is necessary to determine
whether this is indeed the case or if one model of binge-like
consumption offers greater sensitivity than the other, particularly
for sucrose consumption. Although, the fact that we were able
to detect a reduction in both sucrose and ethanol consumption
with varenicline indicates that despite the reduced access time,
the increased number of ethanol exposures and greater initial
and hourly binge-like consumption produced by the DID model
may be sufficient to produce signaling changes within the brain,
similar to that reported with the IA2BC model (see Nielsen
et al., 2012a; Klenowski et al., 2016). Further studies are also
required to determine which aspects of the model (i.e., the
increased number of consumption/withdrawal cycles of the DID
model verses increased total amount consumed per session
of the IA2BC model) are more important for modeling and
producing binge-like consumption, if the DID model produces
brain changes similar to those previously demonstrated with the
IA2BC model for sucrose and ethanol consumption and whether
these changes occur following fewer weeks of ethanol or sucrose
exposure compared to the IA2BC model.
CONCLUSION
The DID model is adaptable for use as a rat model of both
ethanol and sucrose binge-like consumption. It produces higher
initial and hourly consumption of ethanol and sucrose compared
to the IA2BC model, suggesting it induces greater binge-like
consumption. Despite the lower total consumption per session
produced by the DID model, it detected varenicline-induced
reductions in both ethanol and sucrose consumption, similar to
that reported for the IA2BC model. Further studies are required
to dissect the importance of the number of exposures, length of
access and total amount consumed for modeling consumption
behaviors. However our data suggest that the DID model may
offer advantages over the IA2BCmodel, particularly for studying
binge-like consumption of ethanol. Further examination of the
differences produced by eachmodel is required to provide greater
guidance for researchers when assessing the suitability of each
model for their study.
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